Trazodone Augmentation in OCD: A Case Series Report.

Area of Science:

• Psychiatry
• Neuroscience
• Pharmacology

Background:

• Obsessive-compulsive disorder (OCD) is a debilitating mental health condition.
• Selective serotonin reuptake inhibitors (SSRIs) are a common first-line treatment for OCD.
• Previous research suggests trazodone may possess antiobsessional properties.

Purpose of the Study:

• To evaluate the efficacy of trazodone as an augmentation strategy for SSRI-refractory obsessive-compulsive disorder.
• To assess the impact of trazodone on both symptom severity and treatment tolerability in OCD patients.

Main Methods:

• A case series of five patients diagnosed with obsessive-compulsive disorder was studied.
• Trazodone was added as an augmentation agent to existing SSRI therapy for all participants.
• Symptomatic improvement and treatment tolerability were monitored.

Main Results:

• All five patients experienced significant symptomatic improvement after the addition of trazodone.
• In several cases, trazodone augmentation also enhanced the tolerability of the SSRI therapy.
• No adverse events were reported in the context of trazodone augmentation.

Conclusions:

• Trazodone augmentation of SSRI therapy appears to be a promising strategy for managing obsessive-compulsive disorder.
• This approach may be particularly beneficial for patients with treatment-resistant OCD.
• Trazodone may improve both the efficacy and tolerability of SSRI treatment in OCD.